CHAMEDI LEADER COSMETIC SET
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- cosmeceutical, growth factor, medical cosmetics, cha medical
- Category
- Skin Care Set
Apply a video call to the Supplier
CHAMEDITECH
- Verified Certificate
-
9
| Product name | CHAMEDI LEADER COSMETIC SET | Certification | - |
|---|---|---|---|
| Category | Skin Care Set | Ingredients | - |
| Keyword | cosmeceutical , growth factor , medical cosmetics , cha medical | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | - |
| Supply type | - | HS code | - |
Product Information
COSMECEUTICAL by CHA hospital group. 5 Basic Cosmetics. Growth Factors EGF, FGF, VEGF, HGH and raw materials certified for whitening, wrinkle improvement, and skin elasticity. International sales in Qatar, Iran, and more.
EGF, which is an epidermal growth factor, induces cell division and promotes the growth of epidermal cells. EGF promotes the proliferation of fibroblasts, which synthesize epidermal and endothelial cell proliferation and collagen, which is a constituent of the dermis It is an excellent ingredient for skin regeneration.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- YUN KYOUNG WOK
- Address
- 103 Migun techno, Youngsan-dong Yusung-gu, Daejeon, korea
- Product Category
- Medical Devices
- Year Established
- 2013
- No. of Total Employees
- 51-100
- Company introduction
-
CHAMEDITECH is under CHA Medical Group, the biggest and best Medical Group in Korea. CHAMEDITECH is focusing on development and manufacture of bio pharmaceuticals (cell therapy product, biological formulatiuon, and recombinant protein pharmaeutical) basing hyaluronic acid, main raw materials of bio cosmetic products and medical devices, aiming for the commercialization of technology that has been accumulated from researches.
- Main Markets
-
China
South Korea
- Main Product
